HSTO has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
HSTO has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. Histogen's YoY EBITDA Growth for the quarter that ended in Sep. 2023 was 10.48%.
Histogen's EBITDA per Share for the three months ended in Sep. 2023 was $-0.90.
The historical data trend for Histogen's YoY EBITDA Growth can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Histogen Annual Data | |||||||||
Trend | Dec19 | Dec20 | Dec21 | Dec22 | |||||
YoY EBITDA Growth | - | -2,546.45 | 81.22 | 57.90 |
Histogen Quarterly Data | ||||||||||||||||||
Jun19 | Sep19 | Dec19 | Mar20 | Jun20 | Sep20 | Dec20 | Mar21 | Jun21 | Sep21 | Dec21 | Mar22 | Jun22 | Sep22 | Dec22 | Mar23 | Jun23 | Sep23 | |
YoY EBITDA Growth | Get a 7-Day Free Trial | 45.42 | 53.15 | -208.05 | 28.68 | 10.48 |
YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.
Histogen's YoY EBITDA Growth for the fiscal year that ended in Dec. 2022 is calculated as:
YoY EBITDA Growth (A: Dec. 2022 ) | |||||
= | (EBITDA per Share (A: Dec. 2022 ) | - | EBITDA per Share (A: Dec. 2021 )) | / | | EBITDA per Share (A: Dec. 2021 ) | |
= | (-3.271 | - | -7.77) | / | | -7.77 | |
= | 57.90 % |
Histogen's YoY EBITDA Growth for the quarter that ended in Sep. 2023 is calculated as:
YoY EBITDA Growth (Q: Sep. 2023 ) | |||||
= | (EBITDA per Share (Q: Sep. 2023 ) | - | EBITDA per Share (Q: Sep. 2022 )) | / | | EBITDA per Share (Q: Sep. 2022 )) | |
= | (-0.897 | - | -1.002) | / | | -1.002 | |
= | 10.48 % |
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Thank you for viewing the detailed overview of Histogen's YoY EBITDA Growth provided by GuruFocus.com. Please click on the following links to see related term pages.
Joyce Reyes | officer: See Remarks | 10655 SORRENTO VALLEY ROAD, SUITE 200, SAN DIEGO CA 92121 |
Richard W Pascoe | director, officer: See Remarks | C/O SEELOS THERAPEUTICS, INC., 300 PARK AVENUE, 12TH FLOOR, NEW YORK NY 10022 |
Rochelle Fuhrmann | director | C/O WARNER CHILCOTT CORPORATION, 100 ENTERPRISE DRIVE, ROCKAWAY NJ 07866 |
Susan Richards Windham-bannister | director | 78 BLANCHARD ROAD, BURLINGTON MA 01803 |
Moya Daniels | officer: See Remarks | 10655 SORRENTO VALLEY ROAD, SUITE 200, SAN DIEGO CA 92121 |
Susan A. Knudson | officer: See Remarks | 9191 TOWNE CENTRE DRIVE, SUITE 400, SAN DIEGO CA 92121 |
Jonathan Jackson | director, 10 percent owner | C/O HISTOGEN INC., 10655 SORRENTO VALLEY ROAD, SUITE 200, SAN DIEGO CA 92121 |
Gail K Naughton | officer: See Remarks | C. R. BARD, INC., 730 CENTRAL AVENUE, MURRAY HILL NJ 07974 |
David Hugh Crean | director | C/O HISTOGEN INC., 10655 SORRENTO VALLEY ROAD, SUITE 200, SAN DIEGO CA 92121 |
Stephen Chang | director | 12912 CAMINO DEL VALLE, POWAY CA 92064 |
Brian Satz | director | C/O HISTOGEN INC., 10655 SORRENTO VALLEY ROAD, SUITE 200, SAN DIEGO CA 92121 |
Yizhuo Zhang | director | C/O HISTOGEN INC., 10655 SORRENTO VALLEY ROAD, SUITE 200, SAN DIEGO CA 92121 |
Martin Latterich | officer: See Remarks | C/O HISTOGEN INC., 10655 SORRENTO VALLEY ROAD, SUITE 200, SAN DIEGO CA 92121 |
Steven J Mento | director | C/O SANGAMO BIOSCIENCES, INC., 501 CANAL BLVD SUITE A-100, RICHMOND CA 94804 |
Keith W Marshall | officer: EVP, COO & CFO | C/O CONATUS PHARMACEUTICALS INC., 16745 WEST BERNARDO DRIVE, SUITE 200, SAN DIEGO CA 92127 |
From GuruFocus
By GuruFocusNews GuruFocusNews • 03-23-2022
By GuruFocusNews GuruFocusNews • 03-25-2022
By GuruFocusNews GuruFocusNews • 05-12-2022
By Marketwired • 09-18-2023
By GuruFocusNews GuruFocusNews • 06-06-2022
By GuruFocusNews GuruFocusNews • 07-01-2022
By sperokesalga sperokesalga • 04-20-2023
By PurpleRose PurpleRose • 07-27-2022
By GuruFocusNews GuruFocusNews • 05-27-2022
By GuruFocusNews GuruFocusNews • 06-01-2022
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.